Holen Sie sich die Stockscreener-App
0.545
3.81%
-0.0216
Handel nachbörslich:
.53
-0.015
-2.75%
Schlusskurs vom Vortag:
$0.5666
Offen:
$0.56
24-Stunden-Volumen:
63,426
Relative Volume:
0.30
Marktkapitalisierung:
$2.77M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-4.9545
EPS:
-0.11
Netto-Cashflow:
$-16.95M
1W Leistung:
-4.05%
1M Leistung:
+0.93%
6M Leistung:
+249.14%
1J Leistung:
+147.73%
1-Tages-Spanne:
$0.532
$0.5699
1-Wochen-Bereich:
$0.51
$0.599
52-Wochen-Spanne:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Vergleichen Sie MTNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.545 | 2.77M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Matinas Biopharma Holdings, Inc. Announces Resignation of Kathryn Penkus Corzo from Board, Compensation and Nominating and Corporate Governance Committees - Marketscreener.com
Matinas BioPharma announces board member resignation - Investing.com
Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MTNB (Matinas BioPharma Holdings) EPS (Diluted) : $-4.79 (TTM As of Sep. 2024) - GuruFocus.com
MTNB stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com Australia
Maxim Group Reiterates Hold Rating for Matinas BioPharma (NYSEAMERICAN:MTNB) - Defense World
MTNBMatinas BioPharma Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Matinas BioPharma plunges as deal for lead asset falls apart - MSN
Matinas BioPharma mulls wind-down as antifungal therapy deal falls through - Pharmaceutical Technology
Matinas BioPharma stock falls on strategic options (MTNB:NYSE) - Seeking Alpha
Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results - Benzinga
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - The Manila Times
Matinas BioPharma Announces the Termination of MAT2203 - GlobeNewswire
MTNB stock touches 52-week low at $2.87 amid market challenges - Investing.com Canada
Richmond pharma firm Kaléo appoints new chief development officer - The Business Journals
MTNB stock touches 52-week low at $2.87 amid market challenges By Investing.com - Investing.com South Africa
Highbridge Capital Management's Strategic Acquisition in Matinas BioPharma - GuruFocus.com
MTNB stock touches 52-week low at $3.24 amid market challenges - Investing.com Australia
TMT Acquisition Corp Announces Changes to Contribution to Trust Account and the Use of Funds in Trust Account to Pay Dissolution Expenses in Connection with Extension Amendment Proposal - StockTitan
Mativ Holdings, Inc. Announces Pricing of Its $400 Million Offering of Senior Notes - Yahoo Finance
Checking in on Mattel, Inc. (MAT) after recent insiders movement - Knox Daily
TMT Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders - StockTitan
68,521 Shares in Metals Acquisition Limited (NYSE:MTAL) Purchased by Rhumbline Advisers - Defense World
Mativ Holdings offers senior notes to finance existing debt - MSN
30 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Itau Unibanco Holding S.A. - Defense World
Clear Street LLC Reduces Holdings in TMT Acquisition Corp (NASDAQ:TMTC) - Defense World
Highbridge Capital Management LLC Takes $1.69 Million Position in Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) - Defense World
Stock Analysts’ Downgrades for September 18th (ATNM, BHR, CALX, FITB, MEDP, MMSI, MOH, MTRX, NPK, PRMW) - Defense World
Mattel price returns higherForecast today18-09-2024 - Economies.com
Rhumbline Advisers Sells 3,565 Shares of Mativ Holdings, Inc. (NYSE:MATV) - Defense World
Brothers of 18-year-old killed outside Nashville club speak out against gun violence - WKRN News 2
One person shot after multiple people were fighting at Nashville gas station - News Channel 5 Nashville
Mattr sells Brazilian pipe coating business for US$17.5 million | 2024-09-16 | Investing News - Stockhouse Publishing
Implant maker Tenon Medical nearly triples its market capitalization in two days - Kursiv Media
At least 3 dead after overnight shooting in Antioch - Yahoo! Voices
Tenon Medical stock jumps 73% in wake of Nasdaq listing update (NASDAQ:TNON) - Seeking Alpha
Stocks of the Hour: Locksley Resources, MTM Critical Metals, Battery Age Minerals - Finance News Network
Matinas BioPharma (NYSEAMERICAN:MTNB) Shares Gap Up to $3.64 - Defense World
Towercrest Capital Management Invests $299,000 in Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) - MarketBeat
Matinas BioPharma (NYSEAMERICAN:MTNB) Shares Gap Down to $3.72 - MarketBeat
Matinas BioPharma Holdings (FRA:6LJ0) Net Income : €-21.22 Mil (TTM As of Jun. 2024) - GuruFocus.com
Matinas BioPharma (NYSEAMERICAN:MTNB) Hits New 12-Month Low at $3.77 - MarketBeat
Matinas BioPharma implements reverse stock split By Investing.com - Investing.com Australia
Matinas BioPharma (NYSEAMERICAN:MTNB) Shares Up 4,230.1% - MarketBeat
Matinas BioPharma implements reverse stock split - Investing.com
Matinas BioPharma stock hits 52-week low at $4.49 - Investing.com
MATINAS BIOPH. NEW O.N. Trade Ideas — FWB:6LJ0 - TradingView
Matinas BioPharma stock hits 52-week low at $4.49 By Investing.com - Investing.com Canada
Matinas BioPharma (NYSEAMERICAN:MTNB) Hits New 1-Year High at $4.67 - MarketBeat
Matinas BioPharma enacts reverse stock split - Investing.com
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):